DAX20.419 +0,1%ESt504.960 ±0,0%MSCIW3.846 +0,1%Dow44.149 -0,2%Nas20.035 +1,8%Bitcoin96.154 -0,1%Euro1,0515 +0,2%Öl73,75 +0,2%Gold2.715 -0,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T NVIDIA 918422 ABOUT YOU A3CNK4 TUI TUAG50 Siemens Energy ENER6Y Rheinmetall 703000 Amazon 906866 Palantir A2QA4J Bayer BAY001 Mercedes-Benz Group (ex Daimler) 710000 Apple 865985 Allianz 840400 Volkswagen (VW) vz. 766403 Deutsche Telekom 555750 Alphabet A (ex Google) A14Y6F
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
EZB-Zinsentscheid im Fokus: DAX höher -- Asiens Börsen im Plus - OMV kündigt Liefervertrag mit Gazprom - Mercedes Benz: Konstruktive Verkaufsgespräche zu Autohäusern
Top News
Gold könnte Rekordlauf fortsetzen - Risiko Trump Gold könnte Rekordlauf fortsetzen - Risiko Trump
BÖRSE AKTUELL: Das macht der DAX vor dem EZB-Zinsentscheid BÖRSE AKTUELL: Das macht der DAX vor dem EZB-Zinsentscheid
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Ste Virbac SA Aktie

NeuKaufenVerkaufen
323,00 EUR -0,50 EUR -0,15 %
FSE
325,00 EUR -5,00 EUR -1,52 %
PAR
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.2,70 Mrd. EUR

KGV24,96Div. Rendite0,37%

WKN874929

ISINFR0000031577

SymbolVRBCF

Ste Virbac SA Aktien News

DatumMeistgelesen
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 11/2024
GlobeNewswireVirbac: Türkiye: Virbac acquires its companion animal distributor
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 10/2024
Wer­bungSte Virbac SA-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
GlobeNewswireVirbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 09/2024
GlobeNewswireVirbac: erratum short Press release Capital reduction_September 13, 2024
GlobeNewswireVirbac : Public release of the Half-Year Financial Report at 30 June 2024.
GlobeNewswireVirbac : the board of directors announces a capital reduction through cancellation of treasury shares
GlobeNewswireVirbac: Information on the departure of Sébastien Huron
GlobeNewswireVirbac 2024 half-year results
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 08/2024
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 07/2024
GlobeNewswireVIRBAC: exceptional first-half momentum (+16.2% at constant exchange rates) driven by all regions
GlobeNewswireVirbac: Termination of the liquidity contract
GlobeNewswireVIRBAC: exceptional first-half growth and guidance raised for 2024
GlobeNewswireVIRBAC announces executive management changes
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 06/2024
GlobeNewswireVirbac finalizes minority shares’ acquisition of Globion, an Indian poultry vaccines specialist
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 05/2024
GlobeNewswireVirbac : Declaration of the number of shares and voting rights
GlobeNewswireVirbac : Public release of Virbac Annual Report at 31 December 2023 (ESEF format)
GlobeNewswireVIRBAC: Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 03/2024
GlobeNewswireVirbac acquired Sasaeah, a leading animal health player in Japan
GlobeNewswireVirbac: Public Release of the Year-End Consolidated Accounts at 31 December 2023
GlobeNewswireVIRBAC: 2023 ANNUAL RESULTS
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 02/2024
GlobeNewswireVirbac to take a leading position in Japan through the acquisition of Sasaeah
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 01/2024
GlobeNewswireVIRBAC: Annual revenue growth of +4.9% thanks to record fourth-quarter activity at +11.5%
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 12/2023
GlobeNewswireOutlook 2023-2024
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 11/2023
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 10/2023
GlobeNewswireMAR Weekly Report_VIRBAC SA_October 30 to November 3 2023
GlobeNewswireVIRBAC: Virbac acquired a majority stake in Globion, a leading Indian poultry vaccines specialist
GlobeNewswireVIRBAC: revenue growth at the end of September at +2.8% at constant exchange rates and scope thanks to a strong activity rebound in the third quarter (+7.8% at constant exchange rates and scope)
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 0/2023
GlobeNewswireVirbac will enter the fast-growing poultry vaccines segment in India
GlobeNewswireVirbac : Public release of the Half-Year Financial Report at 30 June 2023.

Ste Virbac SA News

Ste Virbac SA News: auf dieser Seite finden Sie alle Ste Virbac SA News und Nachrichten zur Ste Virbac SA Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Ste Virbac SA News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Ste Virbac SA News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.